Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Colgate-Palmolive Company, junto con sus subsidiarias, fabrica y vende productos de consumo en los Estados Unidos e internacionalmente. Opera a través de dos segmentos: Cuidado Bucal, Personal y del Hogar; y Nutrición de Mascotas.
Traducido automáticamente
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | $21.0B | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B | $16.5B | $15.7B | $15.5B | $15.5B | $15.2B | $16.0B | $17.3B | $17.4B | $17.1B | $16.7B | $15.6B | $15.3B | $15.3B | $13.8B | $12.2B |
| Beneficio bruto | $12.7B | $12.3B | $12.1B | $11.3B | $10.2B | $10.3B | $9.9B | $9.3B | $9.2B | $9.3B | $9.1B | $9.4B | $10.1B | $10.2B | $9.9B | $9.6B | $9.2B | $9.0B | $8.7B | $7.9B | $6.9B |
| % de margen bruto | 60.4% | 60.1% | 60.2% | 57.8% | 56.5% | 59.1% | 60.3% | 59.1% | 59.2% | 60.3% | 60.1% | 58.4% | 58.5% | 58.7% | 58.0% | 57.5% | 59.0% | 58.9% | 56.5% | 57.0% | 56.2% |
| Ingresos operativos (EBIT) | $4.3B | $4.3B | $4.4B | $4.1B | $3.6B | $3.9B | $3.9B | $3.8B | $3.9B | $4.0B | $4.0B | $4.0B | $4.2B | $4.1B | $4.0B | $3.9B | $3.8B | $3.7B | $3.3B | $2.9B | $2.6B |
| % de margen operativo | 20.6% | 21.3% | 21.8% | 21.2% | 20.0% | 22.3% | 23.7% | 24.0% | 24.8% | 25.9% | 26.1% | 24.8% | 24.2% | 23.7% | 23.4% | 23.1% | 24.2% | 24.4% | 21.7% | 21.3% | 21.0% |
| Ingresos netos | $2.0B | $2.1B | $2.9B | $2.3B | $1.8B | $2.2B | $2.7B | $2.4B | $2.4B | $2.0B | $2.4B | $1.4B | $2.2B | $2.2B | $2.5B | $2.4B | $2.2B | $2.3B | $2.0B | $1.7B | $1.4B |
| % de margen neto | 9.7% | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% | 8.6% | 12.6% | 12.9% | 14.5% | 14.5% | 14.1% | 14.9% | 12.8% | 12.6% | 11.1% |
| EBITDA | $3.8B | $4.0B | $4.9B | $4.2B | $3.4B | $3.8B | $4.3B | $4.0B | $4.2B | $4.1B | $4.3B | $3.3B | $4.1B | $4.1B | $4.4B | $4.3B | $3.9B | $4.0B | $3.5B | $3.1B | $2.6B |
| Beneficio por acción (EPS) | $2.52 | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 | $1.52 | $2.36 | $2.38 | $2.57 | $2.47 | $2.16 | $2.18 | $1.83 | $1.63 | $1.26 |
| Acciones en circulación (M) | 806M | 811M | 822M | 829M | 839M | 848M | 859M | 861M | 873M | 888M | 898M | 910M | 924M | 940M | 960M | 984M | 1,022M | 1,049M | 1,070M | 1,068M | 1,077M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de CL. /companies/us/CL
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms